Result Summary for NN210010
| Protocol ID: | NN210010 |
| Clinical Study ID: | NN210010 |
| Official Title: | A Phase I, Open Label, Randomized, Three Cohort Study to Investigate the Potential Pharmacokinetic Interaction, Safety and Tolerability of GW695634G 400mg q12h and Three Ritonavir-boosted HIV-1 Protease Inhibitors (Atazanavir, Fosamprenavir and Lopinavir) Following Oral Administration to Healthy ... |
| Phase: | Phase 1 |
| Study Indications or Diseases: |
|
| Generic Name: | fosamprenavir |
| Trade/Product Name: | lexiva;lexiva |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
